RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Ahn-Gook Pharmaceutical Co - Stock

Ahn-Gook Pharmaceutical Co Revenue 2024

Ahn-Gook Pharmaceutical Co Revenue

233.68 B KRW

Ticker

001540.KQ

ISIN

KR7001540004

In 2024, Ahn-Gook Pharmaceutical Co's sales reached 233.68 B KRW, a 13.77% difference from the 205.39 B KRW sales recorded in the previous year.

The Ahn-Gook Pharmaceutical Co Revenue history

YEARREVENUE (undefined KRW)GROSS MARGIN (%)
2023233.6860,16
2022205.3961,48
2021163.5361,77
2020143.3659,22
2019155.8550,04
2018185.7552,65
2017183.650,21
201617440,45
2015197.7441,02
2014167.9441,55
2013153.9744,77
2012140.8344,00
2011129.9550,02
2010112.858,51
2009100.5362,69
200875.9166,87
200764.1367,07
200661.1172,14
200558.4873,45
200446.6173,07

Ahn-Gook Pharmaceutical Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Ahn-Gook Pharmaceutical Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Ahn-Gook Pharmaceutical Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Ahn-Gook Pharmaceutical Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Ahn-Gook Pharmaceutical Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Ahn-Gook Pharmaceutical Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Ahn-Gook Pharmaceutical Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Ahn-Gook Pharmaceutical Co’s growth potential.

Ahn-Gook Pharmaceutical Co Revenue, EBIT and net profit per share

DateAhn-Gook Pharmaceutical Co RevenueAhn-Gook Pharmaceutical Co EBITAhn-Gook Pharmaceutical Co Net Income
2023233.68 B undefined5.06 B undefined1.29 B undefined
2022205.39 B undefined9.68 B undefined6.88 B undefined
2021163.53 B undefined-1.08 B undefined3.94 B undefined
2020143.36 B undefined1.98 B undefined-1.32 B undefined
2019155.85 B undefined2.42 B undefined2.54 B undefined
2018185.75 B undefined15.37 B undefined13.22 B undefined
2017183.6 B undefined10.4 B undefined8.16 B undefined
2016174 B undefined4.17 B undefined1.72 B undefined
2015197.74 B undefined12.93 B undefined9.36 B undefined
2014167.94 B undefined9.8 B undefined-1.37 B undefined
2013153.97 B undefined10.38 B undefined6.53 B undefined
2012140.83 B undefined5.49 B undefined3.63 B undefined
2011129.95 B undefined7.24 B undefined6.47 B undefined
2010112.8 B undefined16.66 B undefined16.36 B undefined
2009100.53 B undefined16.88 B undefined13.98 B undefined
200875.91 B undefined13.05 B undefined3.84 B undefined
200764.13 B undefined11 B undefined8.75 B undefined
200661.11 B undefined10.98 B undefined8.23 B undefined
200558.48 B undefined13.98 B undefined9.71 B undefined
200446.61 B undefined10.9 B undefined8.7 B undefined

Ahn-Gook Pharmaceutical Co stock margins

The Ahn-Gook Pharmaceutical Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Ahn-Gook Pharmaceutical Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Ahn-Gook Pharmaceutical Co.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Ahn-Gook Pharmaceutical Co's sales revenue. A higher gross margin percentage indicates that the Ahn-Gook Pharmaceutical Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Ahn-Gook Pharmaceutical Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Ahn-Gook Pharmaceutical Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Ahn-Gook Pharmaceutical Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Ahn-Gook Pharmaceutical Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Ahn-Gook Pharmaceutical Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Ahn-Gook Pharmaceutical Co Margin History

Ahn-Gook Pharmaceutical Co Gross marginAhn-Gook Pharmaceutical Co Profit marginAhn-Gook Pharmaceutical Co EBIT marginAhn-Gook Pharmaceutical Co Profit margin
202360.16 %2.17 %0.55 %
202261.48 %4.71 %3.35 %
202161.77 %-0.66 %2.41 %
202059.22 %1.38 %-0.92 %
201950.04 %1.55 %1.63 %
201852.65 %8.27 %7.12 %
201750.21 %5.67 %4.44 %
201640.45 %2.39 %0.99 %
201541.02 %6.54 %4.74 %
201441.55 %5.84 %-0.81 %
201344.77 %6.74 %4.24 %
201244 %3.9 %2.57 %
201150.02 %5.57 %4.98 %
201058.51 %14.77 %14.51 %
200962.69 %16.79 %13.91 %
200866.87 %17.19 %5.06 %
200767.07 %17.16 %13.65 %
200672.14 %17.96 %13.47 %
200573.45 %23.9 %16.6 %
200473.07 %23.4 %18.66 %

Ahn-Gook Pharmaceutical Co Aktienanalyse

What does Ahn-Gook Pharmaceutical Co do?

Ahn-Gook Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Ahn-Gook Pharmaceutical Co's Sales Figures

The sales figures of Ahn-Gook Pharmaceutical Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Ahn-Gook Pharmaceutical Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Ahn-Gook Pharmaceutical Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Ahn-Gook Pharmaceutical Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Ahn-Gook Pharmaceutical Co stock

How much revenue did Ahn-Gook Pharmaceutical Co generate this year?

Ahn-Gook Pharmaceutical Co has achieved a revenue of 233.68 B KRW this year.

How much was the turnover of the company Ahn-Gook Pharmaceutical Co compared to the previous year?

The revenue of Ahn-Gook Pharmaceutical Co has increased by 13.77% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Ahn-Gook Pharmaceutical Co?

The revenue of Ahn-Gook Pharmaceutical Co is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Ahn-Gook Pharmaceutical Co measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Ahn-Gook Pharmaceutical Co so important for investors?

The revenue of Ahn-Gook Pharmaceutical Co is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Ahn-Gook Pharmaceutical Co pay?

Over the past 12 months, Ahn-Gook Pharmaceutical Co paid a dividend of 220 KRW . This corresponds to a dividend yield of about 2.99 %. For the coming 12 months, Ahn-Gook Pharmaceutical Co is expected to pay a dividend of 220 KRW.

What is the dividend yield of Ahn-Gook Pharmaceutical Co?

The current dividend yield of Ahn-Gook Pharmaceutical Co is 2.99 %.

When does Ahn-Gook Pharmaceutical Co pay dividends?

Ahn-Gook Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of January, January, January, January.

How secure is the dividend of Ahn-Gook Pharmaceutical Co?

Ahn-Gook Pharmaceutical Co paid dividends every year for the past 20 years.

What is the dividend of Ahn-Gook Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 220 KRW are expected. This corresponds to a dividend yield of 2.99 %.

In which sector is Ahn-Gook Pharmaceutical Co located?

Ahn-Gook Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Ahn-Gook Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ahn-Gook Pharmaceutical Co from 5/1/2024 amounting to 220 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2023.

When did Ahn-Gook Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 5/1/2024.

What was the dividend of Ahn-Gook Pharmaceutical Co in the year 2023?

In the year 2023, Ahn-Gook Pharmaceutical Co distributed 220 KRW as dividends.

In which currency does Ahn-Gook Pharmaceutical Co pay out the dividend?

The dividends of Ahn-Gook Pharmaceutical Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Ahn-Gook Pharmaceutical Co

Our stock analysis for Ahn-Gook Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ahn-Gook Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.